Breast cancer is a heterogeneous disease with varied morphological appearances,
molecular features, behavior, and response to therapy. Current routine clinical management …

Validating prognostic or predictive candidate genes in appropriately powered breast cancer
cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots …

Background A recurrence score based on a 21-gene expression assay predicts the benefit
of adjuvant chemotherapy in oestrogen receptor (ER)-positive, human epidermal growth …

Diffuse optical imaging (DOI) may be a beneficial diagnostic method for women with
mammographically dense breast tissue. In order to evaluate the utility of DOI, we are …

Lymphatic dissemination from the primary tumor is a major mechanism by which breast
cancer cells access the systemic circulation, resulting in distant metastasis and mortality …

Background Adjuvant chemotherapy with anthracyclines improves disease-free and overall
survival compared with non–anthracycline-based adjuvant chemotherapy regimens in the …

The aim of this study was to evaluate the predictive value of five different biological factors in
breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy:(1) …

Purpose To compare the pathologic complete response (pCR) rate and relapse-free survival
(RFS) and overall survival (OS) after neoadjuvant systemic chemotherapy (NST) in patients …

The use of overwhelming reactive oxygen species (ROS) attack has shown great potential
for treating aggressive malignancies; however, targeting this process for further applications …

The aim of this study was to determine the chemosensitivity of infiltrating lobular breast
carcinoma (ILC) in comparison with infiltrating ductal carcinoma (IDC). Between 1987 and …